Abiopharma

🔍 Brennan Ita M (Executive)

Company: Planet Labs PBC (PL)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 36,500 shares of Class A Common Stock at $33.9063 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: false | shares_owned_after: 264,158.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026.
• F2: The sales were executed in multiple trades at prices ranging from $32.86 to $35.14. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F3: Includes (a) 3,478 RSUs that vest in equal quarterly installments on the 15th of June; and (b) 32,468 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.